Term
Risk Factors for Colorectal Cancer |
|
Definition
- Age > 50
- Polyps
- Family history (colorectal cancer syndromes, polyps)
- Geography
- Diet
- Inflammatory Bowel Disease
- Previous colorectal cancer or pelvic irradiation
- Obesity
- Smoking EtOH
- Previous Non-Cancer Surgery?
|
|
|
Term
Familial Adenomatous Polyposis |
|
Definition
- Hundreds to Thousands of tiny adenomatous polyps, evident by age 25
- 3x more common in women
- Autosomal dominant
- Adenomatous Polyposis Coli gene on chromosome #5
- Total colectomy recommended
|
|
|
Term
Hereditary Nonpolyposis Colorectal Cancer |
|
Definition
- Also called Lynch syndrome
- Type 1=no extracolonioc involvement
- Type 2=extracolonic malignancies including ovary, breast, uterus, stomach, or bile duct
- Autosomal dominant -- mismatch repair gene mutations
- Right sided cancers
- Early age of onset
- Should be screened for other malignancies
|
|
|
Term
Possible Negative Risk Factors |
|
Definition
- Aspirin/NSAID use
- HRT in women
- MVI w/ folic acid
- Ca2+ supplements
- High fiber diet
|
|
|
Term
Colorectal Cancer Presentation |
|
Definition
- Early tumors may be asymptomatic
- General signs -- rectal bleeding, abdominal pain, change in bowel habits, abdominal distention
|
|
|
Term
Locational Signs of Colorectal Cancer: Right colon |
|
Definition
- Less symptomatic
- Ulcerative lesions can result in blood loss --> anemia
|
|
|
Term
Locational Signs of Colorectal Cancer: Transverse, Left colon |
|
Definition
|
|
Term
Locational Signs of Colorectal Cancer: Rectum, Sigmoid colon |
|
Definition
- Hematochezia
- Sense of incomplete evacuation
- Painful defecation
- Narrowing of stool shape
|
|
|
Term
Diagnosis of Colorectal Cancer |
|
Definition
- Complete history and physical exam
- Endoscopy, barium enema
- CBC
- Blood chemistry
- LFTs
- CEA (tumor marker) -- nl < 2.5 ng/mL
- Chest X-ray
- Abdominal CT scan
|
|
|
Term
Screening for Colorectal Cancer |
|
Definition
Beginning at age 50 for men and women, the following tests should be performed:
- Sigmoidoscopy every 5 yrs
- Double-contrast barium enema every 5 yrs
- CT colonoscopy (virtual colonoscopy) every 5 yrs
- Colonoscopy every 10 yrs
- Yearly fecal occult blood tests -- however, does not find polyps
|
|
|
Term
|
Definition
- FH of colorectal cancer in first degree relative < 60 yrs old or 2 or more first degree relatives any age -- colonoscopy every 10 yrs starting at 40
- FAP: should have colectomy (no screening)
- HNPCC: colonoscopy every 1-2 yrs from 21-40 then annually thereafter
- IBDs (including UC and Crohn's): colonoscopy yearly
|
|
|
Term
How often should a patient get a colonoscopy if a polyp was found? |
|
Definition
- Repeat screening is more stringnent
- Colonoscopy in 3-6 yrs -- if normal, go back to regular schedule
|
|
|
Term
How often should a patient get a colonoscopy if they are a colon cancer survivor? |
|
Definition
One yr after treatment, repeat in 3 yrs, then every 5 year schedule |
|
|
Term
For a Fecal Occult Blood Test, in order to avoid false positives, you must avoid the following for 3 days prior to test: |
|
Definition
- Red meat
- Turnips, broccoli, cauliflower, and radishes
- Iron supplementation
- Rectal penetration (of ANY sort)
|
|
|
Term
For a Fecal Occult Blood Test, in order to avoid false positives, you must avoid the following for 7 days prior to test: |
|
Definition
|
|
Term
For a Fecal Occult Blood Test, in order to avoid false negatives, you must avoid the following for 3 days prior to test: |
|
Definition
|
|
Term
General Treatment Strategies: Stage I Colorectal Cancer |
|
Definition
Surgery
- resection of primary tumor and regional mesenteric lymph nodes
- Surgery results in a partial colectomy
- Patients frequently will require colostomy bag
|
|
|
Term
General Treatment Strategies: Stage II Colorectal Cancer |
|
Definition
- Surgery THEN Adjuvant Chemotherapy
- 5-FU/Leucovorin for 6 months
|
|
|
Term
General Treatment Strategies: Stage III Colorectal Cancer |
|
Definition
Locally Advanced Disease
- Surgery THEN Adjuvant Chemotherapy
- FOLFOX-4 for 6 months
|
|
|
Term
General Treatment Strategies: Stage IV Colorectal Cancer |
|
Definition
NOT CURATIVE
- Surgery (palliation)
- Chemotherapy + Bevacizumab
FOLFOX-4 + bevacizumab
OR
FOLFIRI + bevacizumab
- Liver mets --> systemic chemo + hepatic artery infusion of floxuridine
|
|
|
Term
|
Definition
Quick
Hypersensitivity
Short Term
- NV
- Myelosuppression
- Alopecia
- Hand-foot syndrome
- Stomatitis
- Diarrhea
|
|
|
Term
|
Definition
Quick
Hypersensitivity
Short Term
- NV
- Myelosuppression
- Alopecia
- Hand-foot syndrome
- Stomatitis
- Diarrhea
- Neuropathies -- oxaliplatin
|
|
|
Term
|
Definition
Quick
Hypersensitivity
Short Term
- NVD
- Myelosuppression
- Alopecia
- Hand-foot syndrome
- Stomatitis
- Neuropathies
- VTEs
- Bowel perforation
- Proteinuria
|
|
|
Term
FOLFIRI/Bevacizumab: ADRs |
|
Definition
Quick
Hypersensitivity
Short Term
- NV
- DIARRHEA
- Myelosuppression
- Alopecia
- Hand-foot syndrome
- Stomatitis
- VTEs
- Bowel perforation
- Proteinuria
|
|
|
Term
General Treatment Strategies: Stage I Rectal Cancer |
|
Definition
Surgery
- resection of primary tumor and regional mesenteric lymph nodes
- Surgery results in a partial colectomy
- Patients frequently will require colostomy bag
|
|
|
Term
General Treatment Strategies: Stage II Rectal Cancer |
|
Definition
- Surgery THEN:
- Adjuvant XRT with continuous infusion 5-FU THEN:
- Chemotherapy with 5-FU/Leucovorin
|
|
|
Term
General Treatment Strategies: Stage III Rectal Cancer |
|
Definition
- Neoadjuvant XRT with 5-FU THEN
- Surgery THEN
- Adjuvant chemo for 6 months with FOLFOX-4
|
|
|
Term
General Treatment Strategies: Stage IV Rectal Cancer |
|
Definition
NOT CURATIVE
- Surgery
- Radiation
- Chemoterapy:
FOLFOX-4 + Bevacizumab
OR
FOLFIRI + Bevacizumab
- Liver mets --> surgery + chemo + hepatic artery infusion of floxuridine
|
|
|
Term
|
Definition
- History and Physical every 3 months for 2 yrs, then every 6 months for total of 5 yrs
- CEA every 3 months for 2 yrs then every 6 months for 2-5 yrs
- Colonoscopy one year after treatment, repeat in 3 yrs, then every 5 year schedule
|
|
|
Term
For Recurrent Rectal Cancer: Good Performance Status |
|
Definition
Combo Therapy
- FOLFOX or FOLFIRI with bevacizumab
- CAPOX (capecitabine + oxaliplatin)
- IROX (irinotecan + oxaliplatin)
- Cetuximab + irinotecan
|
|
|
Term
For Recurrent Rectal Cancer: Poor Performance Status |
|
Definition
Single Agent
- Capecitabine
- Irinotecan
- Cetuximab
|
|
|